SFC FLUIDICS, INC.
FAYETTEVILLE, AR · CIK 0001352226 · Medtech · Private
Wearable patch pump for insulin delivery in diabetes care
sfc-fluidics.com →- Grants
- $8.4M
- 15 awards
- Sector median: 1
- Raised
- $2.1M
- 7 Form D · Oct 2025
- 11 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 12
- 3 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $750,000 | |
| Private capital raised | Form D · SEC | $125,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Portable Brain Injury Biomarker Detection System with Integrated Microdialysis Pr | $747,835 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of an Implantable On-Demand Drug Delivery Device for Behavioral Studies in Small Animals | $175,003 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of an Implantable On-Demand Drug Delivery Device for Behavioral Studies in Small Animals | $215,003 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Portable Brain Injury Biomarker Detection System with Integrated Microdialysis Pr | $706,733 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an Implantable On-Demand Drug Delivery Device for Behavioral Studies in Small Animals | $40,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Low-Profile Dual Hormone Patch Pump with Novel Occlusion Sensor | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an Implantable On-Demand Drug Delivery Device for Behavioral Studies in Small Animals | $750,130 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an Implantable On-Demand Drug Delivery Device for Behavioral Studies in Small Animals | $1,452,213 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Low-Profile Dual Hormone Patch Pump with Novel Occlusion Sensor | $30,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an Implantable On-Demand Drug Delivery Device for Behavioral Studies in Small Animals | $9,647 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an Implantable On-Demand Drug Delivery Device for Behavioral Studies in Small Animals | $692,436 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Low-Profile Dual Hormone Patch Pump with Novel Occlusion Sensor | $748,973 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Low-Profile Dual Hormone Patch Pump with Novel Occlusion Sensor | $648,554 | |
| Private capital raised | Form D · SEC | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Advanced Development of Gemini-DHAP | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Advanced Development of Gemini-DHAP | $944,944 | |
| Private capital raised | Form D · SEC | $250,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1137 | SiDx, Inc. | — | $2.6M |
| 1138 | Cadense, Inc. | — | $2.1M |
| 1139 | TAURUS DIAGNOSTICS, INC | — | — |
| 1140 | SFC FLUIDICS, INC. | — | $2.1M |
| 1141 | RODO MEDICAL, INC. | — | $7.7M |
| 1142 | BioAesthetics Corporation | — | $5.0M |
| 1143 | Nirvana Sciences, Inc. | — | $1.7M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ramsay BallDirector
- Anthony CruzDirector · Executive Officer
- Tony CruzExecutive Officer
- Ingrid FritschDirector · Executive Officer
- Calvin GoforthDirector · Executive Officer · Promoter
- Robert GoforthDirector · Executive Officer
- Bryan HostoDirector
- Mark KiddExecutive Officer
- Abraham LeeDirector
- Yasuhiko MatsudaDirector
- Tetsuya OtaDirector
- Ota TetsuyaDirector
Patents
- Wearable Drug Infusion Deviceapplication
- Metastable State of Dual Latching Valvesgranted
- Measurement of Electric Signals to Detect Presence or Flow of Electroactive Species in Solutiongranted
- Dual Latching Microvalvesgranted
- Dual Latching Microvalvesapplication
- Automated Microfluidic Sample Analyzer Platforms for Point of Careapplication
- Wearable Drug Infusion Deviceapplication
- The Use Of Characteristic Electrochemical Signals For Fluid Identificationapplication
- Measurement Of Electric Signals To Detect Presence Or Flow Of Electroactive Species In Solutionapplication
- Dual Latching Microvalvesapplication
- Microdialysis Platformapplication
- Metastable State Of Dual Latching Valvesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.